RMD vs. ZBH: ResMed vs. Zimmer Biomet Stock Comparison
How do ResMed (RMD) and Zimmer Biomet (ZBH) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.
Company Profile
ResMed (RMD) and Zimmer Biomet (ZBH) are both classified in the Health Care Equipment sub-industry within the broader Health Care Equipment & Supplies industry, placing them in the closest GICS peer bucket.
| Profile Item | RMD | ZBH |
|---|---|---|
| Name | ResMed Inc. | Zimmer Biomet Holdings Inc. |
| Country/Region | United States | United States |
| GICS Sector | Health Care | Health Care |
| GICS Industry Group | Health Care Equipment & Services | Health Care Equipment & Services |
| GICS Industry | Health Care Equipment & Supplies | Health Care Equipment & Supplies |
| GICS Sub-Industry | Health Care Equipment | Health Care Equipment |
| Market Capitalization | 33.10 billion USD | 19.98 billion USD |
| Currency | USD | USD |
| Exchange | NYSE | NYSE |
| Listing Date | June 2, 1995 | July 25, 2001 |
| Security Type | Common Stock | Common Stock |
Price Performance
Cumulative Growth
Trailing Returns
Calendar-Year Returns
Performance Metrics
| Metric | RMD | ZBH |
|---|---|---|
| Total Return (1Y) | -5.42% | 24.04% |
| Total Return (3Y, Annualized) | 18.99% | 2.38% |
| Total Return (5Y, Annualized) | -1.23% | -2.74% |
Risk Profile
Drawdown History
Return Distribution
Risk Metrics
| Metric | RMD | ZBH |
|---|---|---|
| Volatility (1Y, Annualized) | 30.80% | 32.39% |
| Beta (5Y) | 0.75 | 0.42 |
| Max Drawdown (5Y) | -49.04% | -43.94% |
| Avg. Volume (3M) | 1.32M | 2.09M |
Risk-Adjusted Performance
Risk-Return Positioning
Risk-Adjusted Metrics
| Metric | RMD | ZBH |
|---|---|---|
| Sharpe Ratio (1Y) | -0.31 | 0.61 |
| Sortino Ratio (1Y) | -0.43 | 0.93 |
Profitability
ROE (TTM)
ResMed (RMD) at 26.40% sits in the top ROE quartile, while Zimmer Biomet (ZBH) at 6.03% is closer to the peer norm — stronger capital efficiency for RMD.
RMD
Health Care Equipment & Services industry group
26.40%
- Max
- 47.61%
- RMD
- 26.40%
- Q3
- 14.36%
- Median
- 5.45%
- Q1
- -10.67%
- Min
- -47.01%
ZBH
Health Care Equipment & Services industry group
6.03%
- Max
- 47.61%
- Q3
- 14.36%
- ZBH
- 6.03%
- Median
- 5.45%
- Q1
- -10.67%
- Min
- -47.01%
Net Margin (TTM)
ResMed (RMD) at 27.79% retains a top-quartile share of revenue as profit, ahead of Zimmer Biomet (ZBH) at 8.95%, which keeps about the industry-typical share.
RMD
Health Care Equipment & Services industry group
27.79%
- Max
- 29.35%
- RMD
- 27.79%
- Q3
- 9.33%
- Median
- 2.18%
- Q1
- -6.29%
- Min
- -28.46%
ZBH
Health Care Equipment & Services industry group
8.95%
- Max
- 29.35%
- Q3
- 9.33%
- ZBH
- 8.95%
- Median
- 2.18%
- Q1
- -6.29%
- Min
- -28.46%
Operating Margin (TTM)
Both ResMed (RMD) at 34.82% and Zimmer Biomet (ZBH) at 17.35% convert sales into operating profit at a top-quartile rate, pointing to tighter cost discipline before financing and tax.
RMD
Health Care Equipment & Services industry group
34.82%
- Max
- 35.43%
- RMD
- 34.82%
- Q3
- 14.14%
- Median
- 6.81%
- Q1
- -0.28%
- Min
- -16.29%
ZBH
Health Care Equipment & Services industry group
17.35%
- Max
- 35.43%
- ZBH
- 17.35%
- Q3
- 14.14%
- Median
- 6.81%
- Q1
- -0.28%
- Min
- -16.29%
Profitability Metrics
| Metric | RMD | ZBH |
|---|---|---|
| ROE (TTM) | 26.40% | 6.03% |
| ROA (TTM) | 14.76% | 3.81% |
| Net Margin (TTM) | 27.79% | 8.95% |
| Operating Margin (TTM) | 34.82% | 17.35% |
| Gross Margin (TTM) | 61.77% | 69.33% |
Growth
Revenue Growth
Both ResMed (RMD) at 9.85% and Zimmer Biomet (ZBH) at 7.20% land near their industries' usual revenue growth ranges, so top-line momentum looks broadly in line with peers on both sides.
EPS Growth
Only one side can be read here: Zimmer Biomet (ZBH) reports EPS growth of -19.86%, ranked against its industry; ResMed (RMD) has no EPS growth figure this period.
Growth Metrics
| Metric | RMD | ZBH |
|---|---|---|
| Revenue Growth (YoY) | 9.85% | 7.20% |
| Revenue Growth (3Y CAGR) | 10.21% | 5.85% |
| EPS Growth (YoY) | -- | -19.86% |
| EPS Growth (3Y CAGR) | 19.64% | 47.78% |
Financial Strength
Current Ratio (MRQ)
Both ResMed (RMD) at 2.65 and Zimmer Biomet (ZBH) at 1.46 carry current ratio within their industries’ typical mid-ranges, suggesting balanced short-term liquidity relative to peers.
RMD
Health Care Equipment & Services industry group
2.65
- Max
- 7.59
- Q3
- 4.00
- RMD
- 2.65
- Median
- 1.98
- Q1
- 1.37
- Min
- 0.30
ZBH
Health Care Equipment & Services industry group
1.46
- Max
- 7.59
- Q3
- 4.00
- Median
- 1.98
- ZBH
- 1.46
- Q1
- 1.37
- Min
- 0.30
Debt / Equity (MRQ)
ResMed (RMD) at 0.10 keeps leverage in the lower industry quartile, while Zimmer Biomet (ZBH) at 0.60 runs a more typical debt-to-equity mix.
RMD
Health Care Equipment & Services industry group
0.10
- Max
- 1.88
- Q3
- 0.91
- Median
- 0.58
- Q1
- 0.16
- RMD
- 0.10
- Min
- 0.00
ZBH
Health Care Equipment & Services industry group
0.60
- Max
- 1.88
- Q3
- 0.91
- ZBH
- 0.60
- Median
- 0.58
- Q1
- 0.16
- Min
- 0.00
Financial Strength Metrics
| Metric | RMD | ZBH |
|---|---|---|
| Current Ratio (MRQ) | 2.65 | 1.46 |
| Debt / Equity (MRQ) | 0.10 | 0.60 |
| Net Debt / EBITDA | -0.19 | 2.85 |
Dividends
Dividend Yield (TTM)
Both ResMed (RMD) at 1.03% and Zimmer Biomet (ZBH) at 0.90% yield above their industries’ entire benchmark ranges — high enough that dividend safety, not income, becomes the first question.
RMD
Health Care Equipment & Services industry group
1.03%
- RMD
- 1.03%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
ZBH
Health Care Equipment & Services industry group
0.90%
- ZBH
- 0.90%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Payout Ratio (TTM)
Both ResMed (RMD) at 22.40% and Zimmer Biomet (ZBH) at 24.24% pay out more of their earnings than any of their industry peers — the thinnest cover in their groups, so dividend headroom deserves attention.
RMD
Health Care Equipment & Services industry group
22.40%
- RMD
- 22.40%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
ZBH
Health Care Equipment & Services industry group
24.24%
- ZBH
- 24.24%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Metrics
| Metric | RMD | ZBH |
|---|---|---|
| Dividend Yield (TTM) | 1.03% | 0.90% |
| Dividend Payout Ratio (TTM) | 22.40% | 24.24% |
Valuation
P/E Ratio (TTM)
Both ResMed (RMD) at 21.43 and Zimmer Biomet (ZBH) at 26.66 land around their industries’ usual P/E ratio levels — neither is getting a clear earnings-multiple discount or premium versus peers.
RMD
Health Care Equipment & Services industry group
21.43
- Max
- 80.41
- Q3
- 47.62
- Median
- 29.93
- RMD
- 21.43
- Q1
- 21.19
- Min
- 4.21
ZBH
Health Care Equipment & Services industry group
26.66
- Max
- 80.41
- Q3
- 47.62
- Median
- 29.93
- ZBH
- 26.66
- Q1
- 21.19
- Min
- 4.21
P/S Ratio (TTM)
Zimmer Biomet (ZBH) at 2.33 is priced about in line with its industry on P/S ratio, while ResMed (RMD) at 5.77 sits in the pricier quartile — RMD costs more per dollar of sales.
RMD
Health Care Equipment & Services industry group
5.77
- Max
- 8.80
- RMD
- 5.77
- Q3
- 4.32
- Median
- 2.13
- Q1
- 1.10
- Min
- 0.03
ZBH
Health Care Equipment & Services industry group
2.33
- Max
- 8.80
- Q3
- 4.32
- ZBH
- 2.33
- Median
- 2.13
- Q1
- 1.10
- Min
- 0.03
P/B Ratio (MRQ)
Zimmer Biomet (ZBH) at 1.58 sits in the lower P/B ratio quartile against book while ResMed (RMD) at 5.56 is valued near its industry’s middle — ZBH is cheaper on assets, though weigh it against ROE and asset quality.
RMD
Health Care Equipment & Services industry group
5.56
- Max
- 11.68
- Q3
- 6.12
- RMD
- 5.56
- Median
- 3.00
- Q1
- 1.73
- Min
- -1.31
ZBH
Health Care Equipment & Services industry group
1.58
- Max
- 11.68
- Q3
- 6.12
- Median
- 3.00
- Q1
- 1.73
- ZBH
- 1.58
- Min
- -1.31
Valuation Metrics
| Metric | RMD | ZBH |
|---|---|---|
| P/E Ratio (TTM) | 21.43 | 26.66 |
| P/S Ratio (TTM) | 5.77 | 2.33 |
| P/B Ratio (MRQ) | 5.56 | 1.58 |
| Free Cash Flow Yield (TTM) | 3.92% | 7.22% |